Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biolinerx Ltd ADR (BLRX)

Biolinerx Ltd ADR (BLRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 137,098
  • Shares Outstanding, K 47,275
  • Annual Sales, $ 0 K
  • Annual Income, $ -30,020 K
  • 60-Month Beta 2.11
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.78
Trade BLRX with:

Options Overview Details

View History
  • Implied Volatility 101.28%
  • Historical Volatility 34.85%
  • IV Percentile 18%
  • IV Rank 16.00%
  • IV High 260.68% on 08/24/21
  • IV Low 70.90% on 05/19/21
  • Put/Call Vol Ratio 0.01
  • Today's Volume 100
  • Volume Avg (30-Day) 83
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 2,226
  • Open Int (30-Day) 1,617

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.13
  • Number of Estimates 2
  • High Estimate -0.10
  • Low Estimate -0.15
  • Prior Year -0.30
  • Growth Rate Est. (year over year) +56.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.58 +12.40%
on 09/20/21
3.01 -3.65%
on 09/02/21
+0.08 (+2.84%)
since 08/24/21
3-Month
2.58 +12.40%
on 09/20/21
3.62 -19.87%
on 07/06/21
+0.20 (+7.41%)
since 06/24/21
52-Week
1.40 +107.14%
on 10/28/20
6.34 -54.26%
on 05/04/21
+1.26 (+76.83%)
since 09/24/20

Most Recent Stories

More News
BioLineRx Reports Second Quarter 2021 Financial Results and Provides Corporate Update

/PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today reports its financial results for the quarter ended and provides...

BLRX : 2.90 (+3.20%)
BioLineRx to Report Second Quarter 2021 Results on August 18, 2021

/PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, announced today it will release its unaudited financial results for the...

BLRX : 2.90 (+3.20%)
Thinking about buying stock in Exela Technologies, Larimar Therapeutics, Marin Software, Provention Bio, or BioLineRx?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for XELA, LRMR, MRIN, PRVB, and BLRX.

BLRX : 2.90 (+3.20%)
XELA : 2.00 (-6.54%)
LRMR : 12.43 (+3.84%)
MRIN : 10.21 (+19.56%)
PRVB : 6.60 (-2.22%)
Thinking about buying stock in Bridgeline Digital, Seelos Therapeutics, Vistagen Therapeutics, BioLineRx, or Entera Bio?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BLIN, SEEL, VTGN, BLRX, and ENTX.

BLIN : 4.23 (-4.30%)
BLRX : 2.90 (+3.20%)
VTGN : 2.83 (-4.07%)
ENTX : 4.81 (-1.43%)
SEEL : 2.09 (-4.57%)
New Strong Sell Stocks for June 4th

ASLN, BLRX, FLXN, ICMB, and MRNS have been added to the Zacks Rank #5 (Strong Sell) List on June 4, 2021.

BLRX : 2.90 (+3.20%)
FLXN : 6.13 (-7.40%)
MRNS : 12.02 (-3.53%)
ASLN : 3.25 (+0.31%)
ICMB : 5.50 (-0.36%)
BioLineRx Reports First Quarter 2021 Financial Results and Provides Corporate Update

, /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today reports its financial results for the quarter ended and provides...

BLRX : 2.90 (+3.20%)
BioLineRx to Report First Quarter 2021 Results on May 26, 2021

, /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, announced today it will release its unaudited financial results for...

BLRX : 2.90 (+3.20%)
Thinking about buying stock in Chiasma, Athenex, iBio, BioLineRx, or Endra Life Sciences?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CHMA, ATNX, IBIO, BLRX, and NDRA.

IBIO : 1.1700 (unch)
ATNX : 3.22 (-5.85%)
CHMA : 3.76 (-6.00%)
BLRX : 2.90 (+3.20%)
NDRA : 1.8000 (-0.55%)
Parkinson's Disease Therapeutic Market Revenue Is Expected To Cross $8 Billion By 2027

, /PRNewswire/ -- Parkinson's disease (PD) is a neurodegenerative disorder that affects predominately dopamine-producing ("dopaminergic") neurons in a specific area of the brain called substantia nigra. Symptoms...

GWHP : 0.2700 (-11.48%)
ADMS : 4.88 (+0.41%)
BLRX : 2.90 (+3.20%)
AXSM : 33.40 (+1.33%)
NBIX : 94.99 (-0.06%)
Thinking about buying stock in BioLineRx, Cocrystal Pharma, Vaxart, Precipio, or Arrival?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BLRX, COCP, VXRT, PRPO, and ARVL.

ARVL : 13.01 (-1.51%)
COCP : 1.0300 (-2.83%)
VXRT : 8.17 (-3.31%)
BLRX : 2.90 (+3.20%)
PRPO : 2.92 (-1.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Bioline RX Ltd. is a biopharmaceutical development company. BioLineRx is dedicated to building a portfolio of products for unmet medical needs or with advantages over currently available therapies. The Company's portfolio consists of clinical stage candidates including BL-1020 for schizophrenia , BL-1040,...

See More

Key Turning Points

3rd Resistance Point 3.13
2nd Resistance Point 3.02
1st Resistance Point 2.96
Last Price 2.90
1st Support Level 2.80
2nd Support Level 2.69
3rd Support Level 2.63

See More

52-Week High 6.34
Fibonacci 61.8% 4.45
Fibonacci 50% 3.87
Fibonacci 38.2% 3.29
Last Price 2.90
52-Week Low 1.40

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar